Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $201.13B | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $201.06B | Healthcare | Pharmaceuticals | United States | NYSE |
| 3 | $142.28B | Healthcare | Pharmaceuticals | United States | NYSE |
| 4 | $135.12B | Healthcare | Pharmaceuticals | United States | NYSE |
| 5 | $129.80B | Healthcare | Pharmaceuticals | United States | NYSE |
| 6 | $109.22B | Healthcare | Pharmaceuticals | United States | NYSE |
| 7 | $41.73B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 8 | $35.04B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 9 | $27.42B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $19.82B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 11 | $15.08B | Healthcare | Pharmaceuticals | United States | NYSE |
| 12 | $13.56B | Healthcare | Pharmaceuticals | United States | NYSE |
| 13 | $13.18B | Healthcare | Pharmaceuticals | United States | NYSE |
| 14 | $11.72B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 15 | $11.08B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 16 | $9.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 17 | $7.61B | Healthcare | Pharmaceuticals | United States | NYSE |
| 18 | $7.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 19 | $5.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 20 | $5.31B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 21 | $4.57B | Healthcare | Pharmaceuticals | United States | NYSE |
| 22 | $4.39B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 23 | $3.78B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 24 | $3.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 25 | $2.99B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 26 | $2.19B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 27 | $2.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 28 | $2.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 29 | $2.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $1.92B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 31 | $1.83B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 32 | $1.70B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 33 | $1.64B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 34 | $1.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 35 | $1.49B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 36 | $1.43B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 37 | $1.43B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 38 | $1.39B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 39 | $1.37B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 40 | $1.31B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 41 | $1.30B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 42 | $1.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 43 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 44 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 45 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 46 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 47 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 48 | $1.21B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 49 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 50 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 51 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 52 | $1.12B | Healthcare | Pharmaceuticals | United States | NYSE |
| 53 | $1.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 54 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 55 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 56 | $1.07B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 57 | $1.04B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 58 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 59 | $994.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 60 | $985.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 61 | $910.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 62 | $904.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 63 | $896.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 64 | $888.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 65 | $885.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 66 | $834.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 67 | $825.74M | Healthcare | Pharmaceuticals | United States | NYSE |
| 68 | $799.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 69 | $761.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 70 | $752.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 71 | $744.50M | Healthcare | Pharmaceuticals | United States | NYSE |
| 72 | $735.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 73 | $724.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 74 | $721.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 75 | $704.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 76 | $703.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 77 | $701.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 78 | $671.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 79 | $667.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 80 | $603.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 81 | $587.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 82 | $566.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 83 | $565.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 84 | $560.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 85 | $558.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 86 | $557.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 87 | $535.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 88 | $527.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 89 | $521.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 90 | $519.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 91 | $512.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 92 | $490.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 93 | $488.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 94 | $479.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 95 | $458.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 96 | $441.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 97 | $437.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 98 | $435.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 99 | $435.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 100 | $425.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 342 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.